2-Hydroxy-N-(2-hydroxyethyl)propanamide
Common Name: |
2-Hydroxy-N-(2-hydroxyethyl)propanamide |
IUPAC Name: |
2-hydroxy-N-(2-hydroxyethyl)propanamide |
Molecular Formula: |
C5H11NO3 |
SMILES: |
CC(C(=O)NCCO)O |
Inchi: |
1S/C5H11NO3/c1-4(8)5(9)6-2-3-7/h4,7-8H,2-3H2,1H3,(H,6,9) |
Inchi Key: |
RZCHTMXTKQHYDT-UHFFFAOYSA-N |
Cas No: |
5422-34-4 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
3 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
133.15 |
Mass (g/mol) |
133.074 |
Molar Refractivity |
31.47 |
Net Charge |
|
HBD |
3 |
HBA |
3 |
Rt Bonds |
4 |
Rings |
|
TPSA |
69.56 |
Hetero Atoms |
3 |
Heavy Atoms |
9 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
380.00 |
Vapor Pressure (mmHg@25.00 °C) |
|
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.80 |
LogP |
-1.524 |
iLOGP |
0.81 |
XLOGP3 |
-1.40 |
WLOGP |
-1.52 |
MLOGP |
-1.24 |
ESOL Log S |
0.48 |
ESOL Solubility (mg/ml) |
403 |
ESOL Solubility (mol/l) |
3.02 |
ESOL Class: esol_class |
Highly soluble |
Ali Log S |
0.44 |
Ali Solubility (mg/ml) |
367 |
Ali Solubility (mol/l) |
2.76 |
Ali Class |
Highly soluble |
Silicos-IT LogSw |
0.06 |
Silicos-IT Solubility (mg/ml) |
152 |
Silicos-IT Solubility (mol/l) |
1.14 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
0 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-8.11 |
Bioavailability Score |
0.55 |
Caco2 |
0 |
Human Intestinal Absorption |
0 |
Plasm Protein Binding |
0.534 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
1 |
Acute Oral Toxicity |
1.434 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |